Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthmaShailendra Singh, David G. Lambert, J. McDonald et al.|British Journal of Pharmacology|2016Cited by 28
Nociceptin/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized miceNikol Sullo, Bruno D’Agostino, Fiorentina Roviezzo et al.|American Journal of Physiology-Lung Cellular and Molecular Physiology|2013Cited by 23